China · Pharmaceuticals startup
China · VivaVision Biotech, Inc.
VivaVision Biotech, Inc.
Funding reportedLast round: Series D
Follow VivaVision Biotech, Inc. and see its new rounds in your feed.Start following
About VivaVision Biotech, Inc.
VivaVision Biotech, Inc.
is a clinical-stage pharmaceutical company based in China, founded in 2016. The company focuses on developing innovative therapies for ocular diseases, particularly chronic eye conditions and other ophthalmic disorders. Its core business revolves around research and development, aiming to create best-in-class and first-in-class therapies to address unmet needs in both anterior and posterior segment eye diseases. VivaVision's pipeline includes several investigational therapies, such as VVN001 for dry eye disease, VVN539 for glaucoma, and VVN461 for non-infectious ocular inflammation and uveitis. The company is dedicated to advancing treatments for patients suffering from various ocular conditions, including dry eye, glaucoma, and retinal diseases.
What company datasets say VivaVision Biotech, Inc. raised
Funding, as reported
On a portfolio page
Investors who name them
Each firm lists VivaVision Biotech, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health caremedical innovationeye health therapieseye care therapiesmedical researchclinical-stage pharmaceuticalbiotech ophthalmologyvision healthpharmaceuticalclinical researchhospital & health careresearch and developmentmedicalbiotech companyinvestigational drugseye disease research
Built with from their website
ApacheMicrosoft ExchangeMicrosoft 365 Apps & ServicesMicrosoft Exchange OnlineMicrosoft 365Apache HTTP ServerOutlookAlibaba CloudMicrosoft Email Providers
- Sector
- Pharmaceuticals
- Industry code
- NAICS 541714, 325414, SIC 2834, 8731
- Region
- Shang Hai Shi
- Revenue
- 3.1M a year, as listed
- Full record
- Every detail in the company directory
Pharmaceuticals in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put VivaVision Biotech, Inc. in front of investors. Or tell us what we have wrong.